153 related articles for article (PubMed ID: 16243221)
1. Oxcarbazepine in infants and young children with partial seizures.
Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y
Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221
[TBL] [Abstract][Full Text] [Related]
2. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
[TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
Kruszewski SP; Klotz SG
Neurology; 2007 Feb; 68(6):472; author reply 472-3. PubMed ID: 17283329
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic drug interactions in children taking oxcarbazepine.
Sallas WM; Milosavljev S; D'souza J; Hossain M
Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of oxcarbazepine.
May TW; Korn-Merker E; Rambeck B
Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine therapy in very young children: a single-center clinical experience.
Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V
Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787
[TBL] [Abstract][Full Text] [Related]
16. [Oxcarbazepine (Trileptal). An effective and well tolerated new drug as first choice in treatment of focal seizures].
Schmidt D; Elger CE
Nervenarzt; 2000 Oct; 71(10):849-55. PubMed ID: 11082818
[TBL] [Abstract][Full Text] [Related]
17. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.
Sachdeo R; Beydoun A; Schachter S; Vazquez B; Schaul N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2001 Sep; 57(5):864-71. PubMed ID: 11552018
[TBL] [Abstract][Full Text] [Related]
18. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures.
Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP;
Neurology; 2006 Aug; 67(4):679-82. PubMed ID: 16924022
[TBL] [Abstract][Full Text] [Related]
19. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures.
Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP;
Seizure; 2007 Dec; 16(8):670-9. PubMed ID: 17574448
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
